StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$13.88−1.18 (-7.81%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Earnings

SkinHealth Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$69.20M
-2.1% on a year earlier
EPS, Q3 FY2026
-$0.14
-$0.09 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of SkinHealth Systems's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$69.20M-2.1%-$0.14Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$72.10M-7.8%-$0.02Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$64.90M-6.8%-$0.05Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026after the close$82.40M-1.3%-$0.06Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$70.70M-10.3%-$0.09Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$78.20M-13.7%$0.03Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$69.60M-14.5%–Release
Q4 FY2024ended Dec 31, 2024Mar 12, 2025after the close$83.50M-13.7%-$0.08Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$78.80M-19.1%-$0.15Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$90.60M-22.9%-$0.10Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close$81.40M-5.7%-$0.10Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

SkinHealth Systems's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Net salesGAAPFY2026$281.00M – $287.00M–NewNov 5, 2026
Net salesFY2026$280.00M – $290.00M$285.00M – $305.00MLoweredAug 6, 2026
Net salesGAAPFY2026$280.00M – $295.00M–NewMay 7, 2026
Adjusted EBITDAnon-GAAPFY2026$48.00M – $50.00M–NewNov 5, 2026
Adjusted EBITDA (1)non-GAAPFY2026$39.00M – $46.00M$35.00M – $45.00MRaisedAug 6, 2026

Guidance vs results

The last range SkinHealth Systems gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$65.00M – $70.00M$69.20MWithin range
Q2 FY2026Revenue$72.00M – $77.00M$72.10MWithin range
Q1 FY2026Revenue$63.00M – $68.00M$64.90MWithin range
FY2025Revenue$293.00M – $300.00M$300.90MΣ4QAbove range
Q3 FY2025Revenue$65.00M – $70.00M$70.70MAbove range
Q1 FY2025Revenue$61.00M – $66.00M$69.60MAbove range
Q3 FY2024Revenue$70.00M – $80.00M$78.80MWithin range
Q2 FY2024Revenue$96.00M – $102.00M$90.60MBelow range
Q1 FY2024Revenue$77.00M – $83.00M$81.40MWithin range

Guidance history

Every forecast SkinHealth Systems put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$48.00M – $50.00MNew
Nov 5, 2026Net salesFY2026$281.00M – $287.00MNew
Aug 6, 2026Adjusted EBITDA (1)FY2026$39.00M – $46.00MRaised
Aug 6, 2026Adjusted EBITDA (1)Q3 FY2026$5.00M – $7.00MNew
Aug 6, 2026Net salesFY2026$280.00M – $290.00MLowered
Aug 6, 2026Net salesQ3 FY2026$65.00M – $70.00MNew
May 7, 2026Adjusted EBITDAFY2026$35.00M – $45.00MReaffirmed
May 7, 2026Adjusted EBITDAQ2 FY2026$11.00M – $13.00MNew
May 7, 2026Net salesFY2026$280.00M – $295.00MNew
May 7, 2026Net salesQ2 FY2026$72.00M – $77.00MNew
Mar 12, 2026Adjusted EBITDAFY2026$35.00M – $45.00MNew
Mar 12, 2026Adjusted EBITDAQ1 FY2026$3.50M – $5.50MNew
Mar 12, 2026Net salesFY2026$285.00M – $305.00MNew
Mar 12, 2026Net salesQ1 FY2026$63.00M – $68.00MNew
Nov 6, 2025Adjusted EBITDAFY2025$37.00M – $39.00MNew
Nov 6, 2025Net salesFY2025$293.00M – $300.00MNew
Aug 7, 2025Adjusted EBITDAQ3 FY2025$2.00M – $4.00MNew
Aug 7, 2025Adjusted EBITDAFY2025$27.00M – $35.00MRaised
Aug 7, 2025Net salesQ3 FY2025$65.00M – $70.00MNew
Aug 7, 2025Net salesFY2025$285.00M – $300.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases SkinHealth Systems filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Results
  5. Update
  6. Update
  7. Results
  8. News
  9. Results
  10. Update
  11. Update
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?